ET

Elias Toubi

Technion – Israel Institute of Technology IL

272
Publications
13,066
Citations
60
H-Index
141
i10-Index
2.58
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

New Biological Treatment Options in CSU OA

Z. Vadasz, E. Toubi - Unknown Venue, 2021
Cited by 3 Semantic Scholar

Immune-Mediated Coagulopathy in COVID-19 Infection OA

Z. Vadasz, B. Brenner, E. Toubi - Seminars in Thrombosis and Hemostasis, 2020
Cited by 12 Semantic Scholar

Immune Responses in the Elderly

Z. Vadasz, E. Toubi - Unknown Venue, 2020
Cited by 1 Semantic Scholar

Semaphorin3A is a promising therapeutic tool for bronchial asthma

E. Toubi, Z. Vadasz - Allergy. European Journal of Allergy and Clinical Immunology, 2020
Cited by 6 Semantic Scholar

Highlights in Autoimmunity: 2020.

E. Toubi, Z. Vadasz - The Israel Medical Association journal : IMAJ, 2020
Cited by 3 Semantic Scholar

Research Topics

Systemic Lupus Erythematosus Research (58) Urticaria and Related Conditions (52) T-cell and B-cell Immunology (29) Autoimmune Bullous Skin Diseases (29) Immune Cell Function and Interaction (27)

Affiliations

University of Copenhagen
DK 2017 - 2017
St Thomas' Hospital
GB 1996 - 1995
Holy Family Hospital
IN 2025 - 2025
Inserm
FR 2006 - 2006
Technion – Israel Institute of Technology
IL 2026 - 1996

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now